RSS Agios Pharma Says EC Adopted Positive Decision For OMP Status Of Mitapivat In Sickle Cell Disease

Currently reading:
 RSS Agios Pharma Says EC Adopted Positive Decision For OMP Status Of Mitapivat In Sickle Cell Disease

Status
Not open for further replies.

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
6,209
Likes
1,916
Credits
32,769©
Cash
0$
Agios Pharmaceuticals, Inc. (AGIO) announced on Wednesday that the European Commission has issued a favorable decision regarding the orphan medicinal product designation for mitapivat, aimed at treating sickle cell disease. Notably, back in November 2020, the FDA had already granted orphan drug status to mitapivat for the same condition. The company anticipates unveiling the results from its Phase 3 RISE UP study on mitapivat in late 2025.

The material has been provided by InstaForex Company - www.instaforex.com
 
Status
Not open for further replies.
Tips

Similar threads

Top Bottom